We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Professor Emeritus David L. Sackett, Developer of Evidence Based Medicine

By LabMedica International staff writers
Posted on 01 Jun 2015
Professor Emeritus David Lawrence Sackett, MD, widely regarded as the father of evidence based medicine (EBM), died on May 13, 2015, in Canada.

Prof. More...
Sackett obtained his medical degree at the University of Illinois (Champaign, USA) and was drafted into the US Public Health Service in 1962 as a result of the Cuban missile crisis. He received a master’s degree in epidemiology from Harvard University (Boston, MA, USA), and became interested in how the methods of epidemiology could be applied to clinical medicine, calling the combination clinical epidemiology. In 1968, the 32 year old Sackett founded Canada’s first department of clinical epidemiology and biostatistics at McMaster University (Hamilton, ON, Canada), coining the term EBM.

He remained at McMaster University until 1994, when he left to found the international Center for Evidence-Based Medicine at the University of Oxford (United Kingdom). He officially retired from academia and clinical practice in 1999, and returned to Canada to establish the Trout Research & Education Centre at McMaster. During his career, he was instrumental in developing EBM, a medical approach based on scientific evidence and critical appraisal rather than conventional wisdom.

He developed and mentored a new breed of applied clinician-scientists, and worked with them to create and disseminate EBM throughout the world. His collaborative research teams were the first to validate the efficacy of aspirin and carotid endarterectomy for patients with threatened stroke, to develop effective strategies for helping hypertensive patients, and to generate compelling evidence of the effectiveness of nurse practitioners. He published 10 books, about 50 book chapters, and over 400 papers in medical and scientific journals.

“David Sackett was a true transformer of health care. He questioned established beliefs, and explored emerging areas,” said Holger Schünemann, chair of the department of epidemiology and biostatistics at the McMaster School of Medicine. “His legacy is carried forward through his influential role on clinical trials, systematic reviews, evidence-based medicine and health education worldwide.”

Related Links:

University of Illinois
McMaster University
University of Oxford



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new study aims to enhance colorectal cancer prevention by identifying polyp molecular signals (Photo courtesy of Shutterstock)

RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous

Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.